Background and Aims: Endoscopic ultrasound (EUS)-guided transmural drainage using a covered biflanged metal stent (CBFMS) and a conventional tubular biliary covered selfexpandable metal stent (CSEMS) has recently been performed by EUS experts. However, appropriate traction force of the sheath to prevent the migration during stent deployment is well unknown. Herein, we assessed the anchoring force (AF) of the distal flange in CBFMSs and CSEMSs. Methods: The AFs of four CBFMSs (Stents AX, NG, PL, and SX) and six CSEMSs (Stents BF, BP, EG, HN, SP, and WF) were compared in an ex vivo setting. We assessed the AF produced by each stent using an EUS-guided transmural drainage model and an EUS-guided hepaticogastrostomy model consisting of sheet-shaped specimens of the stomach, gelatin gel, and gelatin tubes. Results: For CBFMSs, the maximum AF of Stent AX was significantly higher than those of Stents PL and SX (P < 0.05) in the porcine model. In the gelatin series, all stents except Stent NG showed a nearly similar AF. For CSEMSs, Stents HN, EG, BF, and WF showed gradual AF elevation in the porcine stomach. Stents SP and BP showed a lower AF than the other four stents. For the gelatin setting, the maximum AF of Stents HN, EG, and WF was higher than those of the other stents regardless of the type of specimens. Conclusions: The significance of the AF and traction distance according to the property of various CBFMSs and CSEMSs could be elucidated using ex vivo models.
Introduction
At present, endoscopic ultrasound-guided transmural drainage (EUS-TD) of peripancreatic fluid collections 1 and the bile duct, [2] [3] [4] gallbladder, 5, 6 and pancreatic duct 7, 8 is commonly performed by EUS experts worldwide. At the early stage of EUS-TD, a plastic stent dedicated for endoscopic retrograde cholangiopancreatography has been placed. Subsequently, a conventional tubular biliary covered self-expandable metal stent (CSEMS) has been used for EUS-TD to allow better drainage and avoid procedure-related adverse events. 9, 10 However, there are several clinical issues with the use of CSEMS such as stent migration and incomplete anastomosis owing to misdeployment, the so-called "candy like sign." 11 Thus, a covered biflanged metal stent (CBFMS), which has lumen-apposing properties, has been developed for EUS-TD. [12] [13] [14] [15] [16] Covered biflanged metal stent is based on two concepts. First, large biflanges can be firmly fixed two nonadherent organs to reduce the risk of stent migration. Therefore, the length between the biflanges is short for lumen-apposing stents (1 cm or at least <2 cm). Second, a large distal flange after being fully deployed allows the traction of another distal organ (i.e. cyst wall, gallbladder wall, and gastrointestinal tract wall) close to the gastric wall as "anchor" by pulling back the sheath with the deployed distal flange.
When CBFMS is used for EUS-TD, the most difficult part during this procedure is the deployment of the proximal flange because all CBFMSs are braided-type stents, which have a high shortening rate (up to approximately 50%). A strong traction (pulling back) force of the sheath causes slipping out (inward migration of the distal flange in the stomach), whereas an insufficient traction force causes slipping in (outward migration of the proximal flange in the opposite side organ or abdominal cavity). Therefore, a sufficient traction force of the sheath with the deployed distal flange, that is, "anchoring force (AF)," is an important factor for successful stent deployment.
Recently, we have deployed not only CBFMS but also tubular CSEMS using a similar technique, that is, a > 1-cm distal stent is deployed as an "anchor" (mimics a triangle shape on an ultrasound image), and the sheath with the deployed distal flange is pulled back to reduce the risk of inward migration.
To date, there has only been one study comparing lumenapposing properties using a fully deployed CBFMS. 17 However, this previous study only evaluated the force of the biflanges. In clinical settings, the most important information during the actual EUS-TD procedures is the AF of the distal flange that is deployed while the proximal flange is stored in the sheath. This study aimed to assess the AF of the distal flange in CBFMSs and conventional CSEMSs.
Methods

Measurement of anchoring force of stents
Preparation of sheet-shaped and tube-shaped specimens. Sheet-shaped specimens of the stomach and gelatin gel were prepared for both the EUS-TD model for CBFMS and EUS-guided hepaticogastrostomy (EUS-HGS) model for CSEMS. In addition, gelatin tubes were prepared only for the EUS-HGS model. The gastric wall specimen with a rectangular shape (approximately 10 × 10 cm 2 ) was carved out from whole porcine stomachs (thickness, 8 mm). A hole (diameter, 4 mm) was made at the center of each specimen using a leather punch. The gelatin sheets with thicknesses of 2, 5, and 10 mm were prepared from 40% gelatin (Gelatin from bovine bone; Wako Pure Chemical Industries, Japan) solution. In brief, the gelatin solution warmed at 60°C was poured into polystyrene biological dishes (diameter, 85 mm) to achieve specific depths (i.e. 2, 5, and 10 mm). Plastic rods (diameter, 4 mm; length, 5-12 mm) were placed upright on the center of the dishes before gelation of the gelatin solution started. The dishes were left at room temperature until the rods were fixed by gelation of the gelatin solution and then cooled in a refrigerator to complete the gelation. Gelatin gel sheets with central holes (diameter, 4 mm) were thus obtained. Gelatin tubes were also prepared from the 40% gelatin solution similarly to the preparation of the gelatin sheets, except that a plastic container (inner diameter, 30 mm; height, 30 mm) was used instead of a biological dish. Measurement of anchoring force of covered biflanged metal stent in endoscopic ultrasound-guided transmural drainage model. The AFs of CBFMSs were measured using the EUS-TD model consisting of sheet-shaped specimens, namely, gastric wall and gelatin sheet specimens that mimicked the gastrointestinal tract. Each specimen was placed between a pair of circular weigh units (upper, 700 g or 700 g × 2; lower, 540 g) on which a sandpaper was affixed to avoid the slippage of specimens. The specimen and weigh units were placed on top of a 250-mL separable funnel (Fig. 1a) , which stood on the stage of a mechanical tester (TA.XT plus; Stable Micro Systems, UK). A CBFMS was inserted into the hole of the specimen along the vertical direction and partially deployed as shown in Figure 1b . Then, the catheter was tightly gripped (the stent body was withdrawn from the catheter and kept free, and the guide was gripped) with a custom-made fixture that was fixed on the crosshead of the tester. After completing the setting of the EUS-TD model, the crosshead was moved vertically at a speed of 1 mm/s until the stent passed through the specimen, and the AF-distance curve was obtained. The maximum force in the curve was defined as AF.
Measurement of anchoring force of covered self-expandable metal stent in endoscopic ultrasound-guided hepaticogastrostomy model. The AFs of CSEMSs were measured using the EUS-HGS model consisting of gastric wall specimens and gelatin tube specimens that mimicked the parenchyma of the liver with an intrahepatic bile duct that was in contact with the gastric wall. The AF measurements for the gastric wall were conducted similarly to the EUS-TD model with slight modifications: the use of circular weigh units (upper, 500 g; lower, 660 g) placed on top of a 300-mL glass beaker and the partial deployment of the stent at a length of 20 mm from the head of the catheter (Fig. 2a) .
As for the gelatin tube specimens, the exterior plastic containers were gripped with a tensile grip apparatus (Code A/TG; Stable Micro Systems). The AFs were measured similarly to the gastric wall specimens (Fig. 2b) .
Types of stent. Statistical analysis. Data obtained from the measurements were expressed as mean ± SD (n = 3) and were compared using one-way analysis of variance. Significant differences between groups were identified using the Tukey-Kramer test, and P-values <0.05 were considered to indicate a statistically significant difference.
Results
Covered biflanged metal stent. The results of the distance curve of AF (DCAF) and the AF of CBFMSs obtained by tensile tests using the porcine stomach and gelatin gel membranes of three different thicknesses are shown in Figure 4 . To obtain a sufficient AF according to the length of each stent, a 1-to 3-cm traction distance is necessary. Thus, DCAF should be focused on the 1-to 3-cm traction distance data. In the porcine model, Stent AX had the highest AF at the 1-to 3-cm traction distance (Fig. 4a) . Notably, although the distal flange of all the stents except Stent SX at approximately the 40-mm traction distance slipped out, the distal flange of Stent SX remained attached at the 60-mm traction distance. In the gelatin series, all the stents except Stent NG showed gradual AF elevation up to the 3-cm traction distance and nearly similar AFs (4 to 6 N) ( Fig. 4b-d) . Although the maximum AF of Stent PL was the highest (Fig. 4c,d ), only Stent PL slipped out at approximately the 30-mm traction distance. Stent NG had the slowest increase in the traction force with increases in the traction distance and AF in all the CBFMSs (Fig. 4) . The maximum AFs in CBFMSs are shown in Figure 5 . The maximum AF of Stent AX was higher than those of Stents PL and SX (P < 0.05) in the porcine stomach. In contrast, the maximum AF of Stent NG was significantly lower than those of Stents AX, PL, and SX (P < 0.01) (Fig. 5a ). In the gelatin gel membrane, the maximum AF of Stent NG was significantly lower than those of the other stents (P < 0.01) (Fig. 5b) .
Covered self-expandable metal stent. The DCAFs of the CSEMSs obtained by tensile tests using the gelatin gel and porcine stomach are shown in Figure 6 . To obtain a sufficient AF in the absence of a lumen-apposing and tubular stent, a traction distance of 1 to 2 cm at the most is considered to be appropriate. Notably, the AF decreased over a 2-cm traction distance, and all the stents slipped out in the porcine stomach; however, all of the stents did not slip out up to the 50-mm traction distance in the gelatin gel membrane (Fig. 6 ). Thus, DCAF should be focused on the 1-to 2-cm traction distance data. In the porcine stomach, Stents HN, EG, BF, and WF showed gradual AF elevation (Fig. 6a) . Interestingly, Stents SP and BP showed a low AF compared with the other four stents (Fig. 6a) . On the other hand, in the gelatin gel membrane setting, all the stents except Stent BF showed nearly similar AF curves and AF levels (Fig. 6b) . The maximum AFs of CSEMSs are shown in Figure 7 . There were significant variations in the maximum AF of each stent. Notably, the maximum AFs of Stents HN, EG, and WF were higher than those of the other stents regardless of the type of specimens (Fig. 7b) . Interestingly, the maximum AF in the porcine stomach was much lower than that in gelatin gel membrane.
Discussion
Recently, new devices have been introduced for EUS-guided drainage with accompanying features of a larger diameter and a shorter length, different shapes of the biflanges (e.g. dumbbell or flare), and anti-migration features as dedicated CBFMSs. [12] [13] [14] [15] [16] 18 Of these features, anti-migration flange appears to be the most important to facilitate the correct placement of the stent. To date, numerous CBFMSs have already been used worldwide; however, the AF of each deployed distal flange remains to be fully clarified. Thus, we investigated the maximum AF and the traction length when the distal flange slips out in CBFMSs and CSEMSs. Regarding the gelatin models in CBFMSs, the maximum AF increased to 6-7 N in Stents AX, SX, and PL up to a 30-mm traction distance (Figs 4b-d) ,5b). In contrast, Stent NG showed approximately half AF compared with three other stents as well as a plateau over a 10-mm traction distance. Notably, in the actual 8-mm-thick porcine stomach, the maximum AF of Stents AX, PL, and SX was approximately 3 N, which is half the force in the gelatin model. Notably, Stent NG had only 0.5 N in the porcine stomach (Figs 4a,5a) . There are two possible causes of the discrepancy in the maximum AFs between the porcine stomach and gelatin models: (i) the nonhomogenous thick porcine stomach and (ii) the mucus adhered to the porcine stomach made it slippery for the deployed flange. However, the outcome in the actual porcine stomach appears to be similar to real human organs. Based on both outcomes in the present study, we emphasize that the open distal flange of Stent NG appears to be unsuitable for lumen apposition. Thus, Stent NG, which has a sufficient stent length between flanges, should be used according to the distance of the two organs. On the other hand, Stents AX, PL, and SX are suitable as lumen-apposing stents because of the sufficient AF of the deployed distal flange. The present study clarified the acceptable traction distance before the deployed distal flange slips out, that is, how much distance the deployed distal flange can undergo traction. Interestingly, in the gelatin model (Fig. 4b-d) , the deployed distal flange slipped out at more than 30-mm traction distance regardless of the gelatin thickness. In the porcine stomach, all the stents except Stent SX Anchoring force of covered metal stentssimilarly slipped out at more than 30-mm traction distance. On the other hand, Stent SX did not slip out up to a 50-mm traction distance. We suspected a relatively long retraction part of the deployed distal flange, suggesting a force as anchor, and mucus adhered to the porcine stomach affect this outcome. Furthermore, the early phase (approximately up to 25-mm traction distance) and the late phase (more than 25-mm traction distance) of the traction force curve of Stent SX were similar to that of Stent NG and those of the other stents, respectively (Fig. 4) . The present results suggest that Stent SX requires a longer traction distance (> 40 mm) than the other stents. As the outcome in the porcine stomach may mimic the clinical settings, the results suggest that when Stent SX is used, a sufficient space (as in the case of the stomach) to be able to pull the scope back appears to be necessary compared with other stents. More recently, the "intra-channel stent release technique" as a novel technique for CBFMS deployment has been reported. 19 This technique, which involves the maneuver of stent deployment under complete EUS guidance, requires the proximal flange to be released inside the working channel of the scope. Initially, the distal flange is deployed in the targeted organ, and the sheath with the deployed distal flange is sufficiently pulled toward the punctured organ (mostly the gastric wall) as an anchor under EUS imaging. Consequently, the saucer shape of the distal flange changes into a football shape. Then, the proximal flange is deployed completely from the delivery system in the working channel while simultaneously moving the stent catheter downward to push the stent out of the scope. 19 At this time, it is necessary to keep a certain traction force to maintain the football shape of the distal flange. From the results of the present study, we suggest a 3-N traction force or a 3-cm traction distance for CBFMSs to obtain the appropriate traction force for deploying the proximal flange without stent misdeployment.
We also assessed the AF of various CSEMSs (Figs 6, 7) . Although all of the stents except Stents BF, BP, and SP have approximately 5 N maximum AF in the gelatin membrane, they slipped out at more than 30-mm traction distance. In the porcine stomach, the maximum AF decreased to one-fourth of the maximum AF in the gelatin membrane, and all the stents slipped out at more than 20-mm traction distance. The discrepancy between the porcine stomach and the gelatin model was possibly caused by mucus adhered to the stomach. Our results suggest that CSEMSs cannot provide sufficient AF and that the deployed distal flange will slip out if it is pulled back up at more than 2-cm traction distance. Regarding CSEMSs, the deployed distal flange should not be pulled strongly in the clinical settings. To overcome the potential risk of migration, the intragastric portion of the stent should be long. 9, 20 Nakai et al. 21 reported on EUS-HGS using a partially covered metal stent with the uncovered portion in the bile duct serving as an anchor to prevent distal migration after stent deployment. However, the AF of Stent BP as a partially covered metal stent was lower than the AFs of other fully covered metal stents; this indicates that the uncovered portion will not sufficiently work as an anchor in the duration of stent deployment. Our results also suggest that as the AF of CSEMSs does not work well compared with CBFMs, a long stent should be used.
There are several limitations of the current study. First, the number of measurements (n = 3) may not be sufficient. Second, two organs (stomach and cyst wall/gallbladder/bile duct/jejunum/liver) were not prepared. Third, various situations (e.g. different tract sizes, tract hardness, and size of targeted organs) were not prepared.
In conclusion, the significance of the AF and traction distance according to the property of various CBFMSs and CSEMSs could be elucidated using animal and ex vivo models. We believe that our results will contribute towards appropriate stent deployment to reduce the risk of stent migration in interventional EUS. Figure 7 Anchoring forces of covered self-expandable metal stents against porcine stomachs (a) and gelatin gel tubes (b). The six types of commercial stents tested were as follows: BF, BONASTENT fully covered type; BP, BONASTENT partially covered type; EG, EGIS; HN, HANAROSTENT; SP, NITI-S Biliary SUPREMO; and WF, WallFlex
™ . Anchoring forces were measured in Newtons, and data were expressed as mean ± SD (n = 3). **P < 0.01; *P < 0.05.
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